{"Ticker": "XRAY", "Company": "Dentsply Sirona", "Sector": "Health Care", "Updated": "2021-12-30 12:06:46", "Rating": [{"Date": "2021-10-01", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$74"}, {"Date": "2021-08-09", "Rating": "Reiterated", "Organization": "H.C. Wainwright", "Rating_Change": "Neutral", "Target_Change": "$72 to $66"}, {"Date": "2021-08-06", "Rating": "Reiterated", "Organization": "Barrington Research", "Rating_Change": "Outperform", "Target_Change": "$77 to $79"}, {"Date": "2021-08-05", "Rating": "Resumed", "Organization": "Credit Suisse", "Rating_Change": "Outperform", "Target_Change": "$74"}, {"Date": "2021-03-02", "Rating": "Upgrade", "Organization": "Barrington Research", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$71"}, {"Date": "2021-03-02", "Rating": "Reiterated", "Organization": "H.C. Wainwright", "Rating_Change": "Neutral", "Target_Change": "$55 to $60"}, {"Date": "2021-01-05", "Rating": "Reiterated", "Organization": "H.C. Wainwright", "Rating_Change": "Neutral", "Target_Change": "$49 to $55"}, {"Date": "2020-12-18", "Rating": "Downgrade", "Organization": "Stifel", "Rating_Change": "Buy to Hold", "Target_Change": "$52"}, {"Date": "2020-11-17", "Rating": "Downgrade", "Organization": "Barclays", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$40"}, {"Date": "2020-11-09", "Rating": "Reiterated", "Organization": "H.C. Wainwright", "Rating_Change": "Neutral", "Target_Change": "$45 to $49"}, {"Date": "2020-10-22", "Rating": "Upgrade", "Organization": "Guggenheim", "Rating_Change": "Neutral to Buy", "Target_Change": ""}, {"Date": "2020-08-10", "Rating": "Reiterated", "Organization": "H.C. Wainwright", "Rating_Change": "Neutral", "Target_Change": "$50 to $45"}, {"Date": "2020-06-16", "Rating": "Initiated", "Organization": "Piper Sandler", "Rating_Change": "Overweight", "Target_Change": "$51"}, {"Date": "2020-06-15", "Rating": "Reiterated", "Organization": "H.C. Wainwright", "Rating_Change": "Neutral", "Target_Change": "$38 to $50"}, {"Date": "2020-05-27", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$50"}, {"Date": "2020-05-11", "Rating": "Downgrade", "Organization": "Barrington Research", "Rating_Change": "Outperform to Mkt Perform", "Target_Change": ""}, {"Date": "2020-04-24", "Rating": "Reiterated", "Organization": "H.C. Wainwright", "Rating_Change": "Neutral", "Target_Change": "$51 to $38"}, {"Date": "2020-04-08", "Rating": "Upgrade", "Organization": "Robert W. Baird", "Rating_Change": "Neutral to Outperform", "Target_Change": "$49"}, {"Date": "2020-04-07", "Rating": "Downgrade", "Organization": "Goldman", "Rating_Change": "Buy to Neutral", "Target_Change": "$58 to $40"}, {"Date": "2020-04-02", "Rating": "Upgrade", "Organization": "Wolfe Research", "Rating_Change": "Peer Perform to Outperform", "Target_Change": "$66"}]}